[Possible intervention of immune mechanisms in the genesis and course of human atherosclerosis]

Pathologie-Biologie
|March 1, 1985
PubMed

Insights

Immunoglobulins and complement proteins bind to arterial lesions in atherosclerosis patients. This binding is more pronounced in arteries supplying infarcted areas, suggesting a role in cardiovascular disease progression.

Area of Science:

  • Cardiovascular pathology
  • Immunohistochemistry
  • Atherosclerosis research

Context:

  • Investigating the role of immune components in atherosclerosis.
  • Examining arterial tissues from patients with myocardial or cerebral infarction.
  • Comparing findings with non-atherosclerotic disease controls.

Purpose:

  • To determine the presence and extent of immunoglobulin and complement deposition in atherosclerotic lesions.
  • To compare immune complex deposition in arteries from atherosclerosis patients versus controls.
  • To assess if binding intensity correlates with infarction or arterial pathology.

Summary:

  • Direct immunoenzymatic tests revealed immunoglobulins and complement bound to all examined atherosclerotic lesions, elastic fiber alterations, and lipid infiltrations.
  • Binding was observed in both atherosclerosis and non-atherosclerosis groups, but was generally more intensive in atherosclerosis patients.
  • Arteries supplying infarcted areas showed more intensive binding, indicating a potential link between immune deposition and ischemic events.

Impact:

  • Provides evidence for immune system involvement in the pathogenesis of atherosclerosis.
  • Suggests potential diagnostic or therapeutic targets related to immunoglobulin and complement pathways.
  • Highlights the association between immune deposition and ischemic complications in cardiovascular disease.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...